top of page


Becoming a global key player 
for CDMO services in the field 
Cell & Gene Therapies 


  • ESC Biotech is a company with his headquarter based in London with R&D and production center at Basel, Switzerland.

  • We are a biotechnology and pharmaceutical manufacturing company aiming to become Europe’s first and leading end-to-end service Contract Development & Manufacturing Organization (CDMO).

  • ESC Biotech focus on  highly sophisticate medicinal products such as Cell & Gene Therapies (CGT) and vaccines. We are also offering the associated Fill & Finish operation capabilities in house.

  • We are thus helping to meet growing medical needs by providing state-of-the-art development and manufacturing capacity in Switzerland for oncology, vaccines and rare diseases.



Due to the long experience of the team and reserved buildings in the life science hotspot Basel, ESC Biotech can set-up new production capacities and advanced technology.

Our service includes :

  1. Rapid deployment of End-to-End CDMO services encompassing program management, CM activities, project management, QA, RA, clinical support to streamline and accelerate progress to clinic and commercialization.

  2. Installations include:

    • Modular production suites (19x50m) on approx. 3.300m total area (phase I) responsive to flexible scaling requirements of CDMO’s.

    • State-of-the-art laboratories include controlled rate freezing and cryo-storage area, process development laboratories, Quality Control laboratory, Environmental Monitoring laboratory and warehouse.

    • Independent HVAC system to ensure full autonomy and independent maintenance management.

  3. Proprietary “Process Reinforcement Technology” (PRT) as a novel concept enabling rapid execution of late-stage clinical development.

  4. Certified Training Courses for operators focusing on CGT requirements.


bottom of page